The emerging era of pharmacogenomics: current successes, future potential, and challenges.
about
From Metabonomics to Pharmacometabonomics: The Role of Metabolic Profiling in Personalized MedicineePGA: A Web-Based Information System for Translational PharmacogenomicsPathogenic variants for Mendelian and complex traits in exomes of 6,517 European and African Americans: implications for the return of incidental resultsComparison of 2 models for gene-environment interactions: an example of simulated gene-medication interactions on systolic blood pressure in family-based data.A study to explore the correlation of ABCB1, ABCG2, OCT1 genetic polymorphisms and trough level concentration with imatinib mesylate-induced thrombocytopenia in chronic myeloid leukemia patients.A physiome interoperability roadmap for personalized drug development.Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease: A Randomized Trial.Towards a Model-Based Dose Recommendation for Doxorubicin in Children.Pharmacometabonomics in humans: a new tool for personalized medicine.Pharmacogenomics study of thiazide diuretics and QT interval in multi-ethnic populations: the cohorts for heart and aging research in genomic epidemiology.The global spectrum of protein-coding pharmacogenomic diversity.Pharmacogenetics of anthracyclines.Pharmacogenetics informed decision making in adolescent psychiatric treatment: a clinical case report.Pharmacogenetics of platinum-based chemotherapy in non-small cell lung cancer: predictive validity of polymorphisms of ERCC1.Introducing personalized health for the family: the experience of a single hospital system.HLA-Cw6-positive patients with psoriasis show improved response to methotrexate treatment
P2860
Q28067029-3F7005A5-7031-40C0-8B57-B2A0A96FC0A7Q28554117-C7547682-7A40-4165-ACF3-E786A9AE7F8BQ30408185-7AE52A2E-5345-499E-93C3-E0ED93A73416Q31149288-38C19054-2362-4905-BC1C-B8C8F3E6D73BQ33427392-8107F169-33AF-40FB-9956-04E50C2ABEA4Q36596051-74D56350-4B9D-448C-A8AA-63B261F2DC21Q37164458-4F96F21F-2F90-46E4-9A0D-16DF777D40E4Q37650674-680E932C-0067-45E3-BB02-D3182165AC9DQ38452107-A982E847-A650-4A45-AC86-A34F1D6A6AA2Q38655838-CEC54C61-7EE3-47A2-ABBA-934CF2A7D209Q38806047-CD3ECDE3-9F50-45B7-A549-50DF4EFC0EFAQ38856218-7C06EA1B-9A94-462D-96A1-7F3787CFBA89Q39035865-820CA99A-0F6A-4BA5-9276-CAF65EFB0C67Q47309064-A5D79624-9BB1-4677-861E-31AD636FB46DQ50072065-071C6DB3-D62C-4FE9-B2E2-F8C3135D9974Q57638728-2D25E88D-850B-45D5-8CED-64F76A78F89B
P2860
The emerging era of pharmacogenomics: current successes, future potential, and challenges.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The emerging era of pharmacoge ...... ure potential, and challenges.
@en
type
label
The emerging era of pharmacoge ...... ure potential, and challenges.
@en
prefLabel
The emerging era of pharmacoge ...... ure potential, and challenges.
@en
P2860
P50
P921
P356
P1433
P1476
The emerging era of pharmacoge ...... ure potential, and challenges.
@en
P2860
P356
10.1111/CGE.12392
P577
2014-05-09T00:00:00Z
2014-07-01T00:00:00Z